Core Scientific
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Core Scientific generated cash of $65,114,000, which is less than the previous year. Cash used in financing activities reached the amount of -$44,649,000 last year. Net change in cash is therefore $17,469,000.
Cash Flow
| 2019 | -832K | -37.36M | 28.69M |
|---|---|---|---|
| 2022 | 205.18M | -590.77M | 306.15M |
| 2023 | 65.11M | -2.99M | -44.64M |
CORZ Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2019 | |
|---|---|---|---|
Cash at beginning of period | 52.24M | 131.67M | 16.40M |
Operating activities | |||
Net income | -246.48M | -2.14B | -11.92M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
Depreciation and amortization | 96.44M | 226.09M | 6.11M |
Stock-based compensation expense | 58.89M | 182.89M | 2.88M |
| Deferred income tax benefit | 58.89M | 182.89M | 2.88M |
| Changes in operating assets and liabilities: | |||
Accounts receivable, net | -744K | -7.57M | -83K |
Inventories | 0 | 0 | 0 |
Accounts payable | 118.59M | 26.71M | 0 |
Cash generated by operating activities | 65.11M | 205.18M | -832K |
Investing activities | |||
Purchases Of Investments | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -16.16M | -383.98M | -37.41M |
Acquisitions Net | 0 | 0 | 0 |
Cash generated by investing activities | -2.99M | -590.77M | -37.36M |
Financing activities | |||
Common Stock Issued | 0 | 0 | 29.52M |
Payments for dividends | 0 | 0 | 0 |
Repurchases of common stock | 0 | -31.64M | 0 |
Repayments of term debt | -40.99M | 117.74M | -832K |
Cash used in financing activities | -44.64M | 306.15M | 28.69M |
Net Change In Cash | 17.46M | -79.43M | -9.49M |
Cash at end of period | 69.70M | 52.24M | 6.90M |
| Data source | Data source |